148 related articles for article (PubMed ID: 11310591)
1. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists.
Strappaghetti G; Corsano S; Barbaro R; Giannaccini G; Betti L
Bioorg Med Chem; 2001 Mar; 9(3):575-83. PubMed ID: 11310591
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position: structure-activity relationships at adenosine receptors.
Müller CE; Shi D; Manning M; Daly JW
J Med Chem; 1993 Oct; 36(22):3341-9. PubMed ID: 8230124
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships in a series of 8-substituted xanthines as bronchodilator and A1-adenosine receptor antagonists.
Corsano S; Strappaghetti G; Scapicchi R; Lucacchini A; Senatore G
Arch Pharm (Weinheim); 1995 Sep; 328(9):654-8. PubMed ID: 7487422
[TBL] [Abstract][Full Text] [Related]
4. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Kim SA; Marshall MA; Melman N; Kim HS; Müller CE; Linden J; Jacobson KA
J Med Chem; 2002 May; 45(11):2131-8. PubMed ID: 12014951
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists.
Grahner B; Winiwarter S; Lanzner W; Müller CE
J Med Chem; 1994 May; 37(10):1526-34. PubMed ID: 8182711
[TBL] [Abstract][Full Text] [Related]
7. Impact of the aryl substituent kind and distance from pyrimido[2,1-f]purindiones on the adenosine receptor selectivity and antagonistic properties.
Drabczyńska A; Schumacher B; Müller CE; Karolak-Wojciechowska J; Michalak B; Pekala E; Kieć-Kononowicz K
Eur J Med Chem; 2003 Apr; 38(4):397-402. PubMed ID: 12750027
[TBL] [Abstract][Full Text] [Related]
8. Aza-analogs of 8-styrylxanthines as A2A-adenosine receptor antagonists.
Müller CE; Sauer R; Geis U; Frobenius W; Talik P; Pawlowski M
Arch Pharm (Weinheim); 1997 Jun; 330(6):181-9. PubMed ID: 9264243
[TBL] [Abstract][Full Text] [Related]
9. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
10. Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor.
Beauglehole AR; Baker SP; Scammells PJ
J Med Chem; 2000 Dec; 43(26):4973-80. PubMed ID: 11150167
[TBL] [Abstract][Full Text] [Related]
11. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
Shimada J; Suzuki F; Nonaka H; Ishii A
J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
[TBL] [Abstract][Full Text] [Related]
12. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
13. Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors.
Jacobson KA; Shi D; Gallo-Rodriguez C; Manning M; Müller C; Daly JW; Neumeyer JL; Kiriasis L; Pfleiderer W
J Med Chem; 1993 Sep; 36(18):2639-44. PubMed ID: 8410976
[TBL] [Abstract][Full Text] [Related]
14. 8-(Sulfostyryl)xanthines: water-soluble A2A-selective adenosine receptor antagonists.
Müller CE; Sandoval-Ramírez J; Schobert U; Geis U; Frobenius W; Klotz KN
Bioorg Med Chem; 1998 Jun; 6(6):707-19. PubMed ID: 9681137
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
Dalpiaz A; Townsend-Nicholson A; Beukers MW; Schofield PR; IJzerman AP
Biochem Pharmacol; 1998 Dec; 56(11):1437-45. PubMed ID: 9827575
[TBL] [Abstract][Full Text] [Related]
17. A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives.
Ferrarini PL; Mori C; Manera C; Martinelli A; Mori F; Saccomanni G; Barili PL; Betti L; Giannaccini G; Trincavelli L; Lucacchini A
J Med Chem; 2000 Jul; 43(15):2814-23. PubMed ID: 10956189
[TBL] [Abstract][Full Text] [Related]
18. Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists.
Peet NP; Lentz NL; Dudley MW; Ogden AM; McCarty DR; Racke MM
J Med Chem; 1993 Dec; 36(25):4015-20. PubMed ID: 8258823
[TBL] [Abstract][Full Text] [Related]
19. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
Kim YC; Ji X; Melman N; Linden J; Jacobson KA
J Med Chem; 2000 Mar; 43(6):1165-72. PubMed ID: 10737749
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.
Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI
Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
